Skye Bioscience Inc (SKYE)

[Closewatcher]

I dont think anybody expects the $20 mill injection to get to approval stage, nor should it even be discussed. All it needs to do is get us to higher valuations for another moderate raise that brings us to Phase 3 trials.

The 502(b) filing for NB1222 is infinitely less costly than a normal NDA process, and they've directed much of their focus to this. Once they get past the first Phase 2 trials, the market cap will undoubtedly allow for a another large raise that doesnt dilute to heavy.

In a perfect world, share price gets to 5+ in 2018 then, raise another 100 million for 20,000,000 shares, giving us capital for other indications and completion of Phase 3 for CINV. At that point we'll have enough champagne to pass around from the share price increase : )